Study Indicates Neurosurgical Procedure Used to Measure Dopamine and Serotonin Is Safe

Scientists at Wake Forest University School of Medicine have demonstrated that a neurosurgical procedure used to research and measure dopamine and serotonin in the human brain is safe.

Their findings are published online in PLOS One, a journal published by the Public Library of Science.

Ohio State Among First In Nation To Implant New Deep-Brain Stimulation Device

COLUMBUS, Ohio – The team of neurologists and neurosurgeons at The Ohio State University Wexner Medical Center and its Neurological Institute are among the first in the nation to implant a new deep-brain stimulation (DBS) device that will help improve the quality of life of patients with Parkinson’s disease.

Henry Ford Health System First in the U.S. to Offer Next Generation Deep Brain Stimulation System For Parkinson’s Disease

The Parkinson’s Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson’s disease. Neurosurgeon Jason Schwalb, M.D. surgically implanted the Vercise Genus™ Deep Brain Stimulation (DBS) System, which stimulates a targeted region of the brain through implanted leads that are placed in the brain.